CIK 0001400118 · <br>Emerging growth company
Sagimet Biosciences Inc.
Sign in to watch- Ticker
- SGMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205991472
- Phone
- (650) 561-8600
- Business address
- 950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
- Former names
- 3-V Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Option exercise | +13,404 | $0.79 | $11K | 3,820,937 |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Sale | −662 | $16.00 | $11K | 3,820,275 |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Purchase | +30,000 | $16.00 | $480K | 3,850,275 |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Conversion · Series B Preferred Stock | −1,301,130 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Conversion · Series B-1 Preferred Stock | −11,363,635 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Conversion · Series C Preferred Stock | −11,363,634 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Conversion · Series D Preferred Stock | −14,659,091 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Conversion · Series E Preferred Stock | −237,893,958 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Conversion · Series F Preferred Stock | −23,041,474 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Option exercise · Common Stock Warrant (right to buy) | −13,404 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Other disposition | −38,763 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Other acquisition | +38,763 | 38,763 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion | +1,860,712 | 1,899,475 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion · Series A Preferred Stock | −539,006 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion · Series B Preferred Stock | −493,370 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion · Series B-1 Preferred Stock | −8,596,590 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion · Series C Preferred Stock | −8,596,589 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion · Series D Preferred Stock | −6,103,580 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion · Series E Preferred Stock | −103,127,234 | 0 | ||
| 2023-07-18 | KPCB PBD Associates, LLC 10% owner | Conversion · Series F Preferred Stock | −20,430,107 | 0 |
Page 6 of 10 · 194 trades